Curis Lifesciences Limited (NSE:CURIS)

Market Cap	840.78M
Revenue (ttm)	496.32M +133.5%
Net Income	61.05M +1,100.6%
EPS	10.29 +1,012.8%
Shares Out	8.08M
PE Ratio	10.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,000
Average Volume	7,750
Open	104.40
Previous Close	104.00
Day's Range	104.00 - 104.40
52-Week Range	98.00 - 147.90
Beta	n/a
RSI	38.80
Earnings Date	May 29, 2026

About Curis Lifesciences

Curis Lifesciences Limited operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India. The company's business model operates through loan license manufacturing, through which, the company carry outs manufacturing under Loan License arrangement for domestic suppliers, where all raw materials and excipients are procured and delivered by the client; contract manufacturing, where the comp...

• Industry: Commercial Physical and Biological Research
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: CURIS

Financial Performance

In fiscal year 2025, Curis Lifesciences's revenue was 496.32 million, an increase of 39.59% compared to the previous year's 355.56 million. Earnings were 61.05 million, an increase of 25.44%.